Study challenges link between proton pump inhibitors and kidney disease risk

A study in Scientific Reports investigates the association between proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RA) use on chronic kidney disease (CKD) risk.

GrowGeneration Q1 Revenue Increases 4% Sequentially

GrowGeneration Reports First Quarter 2023 Financial Results Net Revenue of $57 million Represents Sequential Improvement from Prior Quarter Gross Margin Improved Substantially to 28.7% Net

May 10, 2023

NCCN visits Vietnam in continued cancer care collaboration – Pharmaceutical Technology

The National Cancer Hospital (K Hospital) in Hanoi is hosting the ‘Best of ASCO 2024’ event. Credit: Chau Doan / Getty. Leaders from the National

November 1, 2024

Eli Lilly’s new maneuvers in GLP-1 treatment

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.